Patents by Inventor Charles Gilson

Charles Gilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
    Publication number: 20070275949
    Abstract: The present invention relates to substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: October 21, 2004
    Publication date: November 29, 2007
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: Brian Smith, Jeffrey Schultz, Charles Gilson III, Scott Estrada
  • Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
    Publication number: 20070142357
    Abstract: The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
    Type: Application
    Filed: June 16, 2004
    Publication date: June 21, 2007
    Inventors: Brian Smith, Charles Gilson, Jeffrey Schultz, Jeffrey Smith